German Researchers Create Non-invasive Lab-on-a-Chip Biosensor That Detects Antibiotic Levels from Breath Samples

Should the device prove effective, it could replace invasive point-of-care blood draws for clinical laboratory testing during patient drug therapy monitoring What if it were possible to perform therapeutic drug monitoring (TDM) without invasive blood draws using breath alone? Patients fighting infections in hospitals certainly would benefit. Traditional TDM can be a painful process for patients, one that also brings risk of bloodline infections. Nevertheless, regular blood draws have been the...

Innovations in Microsampling Blood Technology Mean More Patients Can Have Blood Tests at Home, and Clinical Laboratories May Advance Toward Precision Medicine Goals

Clinical laboratory leaders aiming for patient-centered care and precision medicine outcomes need to acknowledge that patients do not want to be in hospitals or travel to physician offices and patient care centers for blood tests. It can be inconvenient, sometimes costly, and often painful. That’s why disease management methods such as remote patient monitoring are appealing to many people. It’s a big market estimated to reach $1 billion by 2020, according to a Transparency Market Research...

JCAHO Has Hospitals Scrambling to Reach Medication-Reconciliation Goal, Why McCleod Hospital in Florence, South Carolina Is an Early Success

Laboratory directors and pathologists are probably watching the scramble inside hospitals to meet new requirements for “medication-reconciliation.” Medication-reconciliation was first brought up by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) in 2004, when they stated that it would be a goal on their 2005 Hospital National Patient Safety Goals. The goal was as follows: Goal 8 Accurately and completely reconcile medications across the continuum of care....
;